To include your compound in the COVID-19 Resource Center, submit it here.

Damage potential

New cancer drug combo treats autoimmune disease

Although cancer drugs have proven effective in treating autoimmune diseases, their intolerable long-term toxicity has discouraged new players from exploring their potential. A group at University of Cincinnati has discovered a new combination that kills activated autoimmune lymphocytes, while sparing cells typically crippled by chemotherapy.

Because standard treatment involves blanket immune suppression, the goal is to produce a system for achieving

Read the full 614 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers